{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK6506/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK6506","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6506\",,,,,undefined,":{"symbol":"BK6506","market":"SI","secType":"PLATE","nameCN":"Pharmaceuticals & Medical Research","latestPrice":1.5666296e-7,"timestamp":1770714839262,"preClose":1.560111e-7,"halted":0,"volume":33293700,"delay":0,"changeRate":0.004178,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":0,"latestTime":"02-10 17:16:00 SGT","open":1.5604564e-7,"high":1.5772981e-7,"low":1.5604564e-7,"amount":9426855.6,"amplitude":0.010795,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770769800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1770683400000,1770696000000],[1770699600000,1770714960000]],"pbRate":1.689894,"peRate":10.882047,"turnoverRate":0.027881,"increases":2,"decrements":1,"flats":4,"marketCap":6723762984,"floatMarketCap":3934947515.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK6506\",,,,,undefined,":{"symbol":"BK6506","high":1.5772981e-7,"amplitude":0.010795,"preClose":1.560111e-7,"low":1.5604564e-7,"pbRate":"1.689894","latestPrice":1.5666296e-7,"volume":33293700,"delay":0,"open":1.5604564e-7,"prevYearClose":1.4808467e-7,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0,"secType":"PLATE","market":"SI","turnoverRate":0.027881,"peRate":10.882047,"marketCap":6723762984,"floatMarketCap":3934947515.625,"timestamp":1770714839262,"nameCN":"Pharmaceuticals & Medical Research"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK6506\",,,,undefined,":{"bkCode":"BK6506","up":2,"down":1,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK6506\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609559180","title":"Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609559180","media":"MT Newswires","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609559180?lang=en_us&edition=fundamental","pubTime":"2026-02-06 14:17","pubTimestamp":1770358637,"startTime":"0","endTime":"0","summary":"JinYao Global, a subsidiary of Tianjin Pharmaceutical Da Ren Tang's  controlling shareholder, Tianjin Pharmaceutical, acquired additional S-Shares in the company at $2.96 apiece for $242,953, according to a Thursday filing with the Singapore Exchange.Shares of the pharmaceutical company were up over 3% in Friday trading.JinYao acquired 82,200 S-shares, representing around 0.0107% of the company's issued share capital. Following the acquisition of the new shares, the controlling shareholder's stake has increased to 43.008%.Meanwhile, JinYao Global has proposed to increase the shareholding further within six months, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6079","T14.SI","BK6506"],"gpt_icon":0},{"id":"2606567798","title":"Lonza's Attributable Profit Rises in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2606567798","media":"MT Newswires","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606567798?lang=en_us&edition=fundamental","pubTime":"2026-01-28 15:28","pubTimestamp":1769585333,"startTime":"0","endTime":"0","summary":"Lonza's  attributable profit to equity holders for 2025 jumped to 949 million Swiss francs from 636 million francs a year earlier, according to a Wednesday filing with the Singapore Exchange.Earnings per share of the pharmaceutical firm rose to 13.51 francs from 8.49 francs a year earlier.Sales jumped 19% year over year to 6.53 billion francs from 5.48 billion francs.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["O6Z.SI","BK6506"],"gpt_icon":0},{"id":"2606376832","title":"Haw Par Corporation Limited's (SGX:H02) top owners are retail investors with 37% stake, while 36% is held by private companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2606376832","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606376832?lang=en_us&edition=fundamental","pubTime":"2026-01-28 06:00","pubTimestamp":1769551255,"startTime":"0","endTime":"0","summary":"Key Insights Significant control over Haw Par by retail investors implies that the general public has more power to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/haw-par-corporation-limiteds-sgxh02-top-owners-are-retail-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/pharmaceuticals-biotech/sgx-h02/haw-par-shares/news/haw-par-corporation-limiteds-sgxh02-top-owners-are-retail-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["H02.SI","IE0031814969.USD","BK6506","SG9999006266.SGD","BK6079"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}